Efficacy of Enteric-Release Oral Budesonide in Treatment of Acute Reactions to Gluten in Patients With Celiac Disease

Clin Gastroenterol Hepatol. 2020 Jan;18(1):254-256. doi: 10.1016/j.cgh.2019.03.029. Epub 2019 Mar 21.

Abstract

Celiac disease (CeD) is a common gluten-responsive T cell-mediated enteropathy. The only current treatment is gluten avoidance; however, even when attempting to adhere to a gluten-free diet (GFD), symptomatic gluten exposures are frequent.1.

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Oral
  • Adolescent
  • Adult
  • Aged
  • Anti-Inflammatory Agents / administration & dosage*
  • Budesonide / administration & dosage*
  • Celiac Disease / diet therapy
  • Celiac Disease / drug therapy*
  • Diet, Gluten-Free
  • Female
  • Gastrointestinal Agents / administration & dosage*
  • Glucocorticoids / administration & dosage
  • Glutens / adverse effects*
  • Humans
  • Intestine, Small / drug effects
  • Middle Aged
  • Recurrence
  • Retrospective Studies
  • Symptom Flare Up
  • Tablets, Enteric-Coated / administration & dosage
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Gastrointestinal Agents
  • Glucocorticoids
  • Tablets, Enteric-Coated
  • Budesonide
  • Glutens